David E. J. Jones

发表

Rituximab Is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A Phase 2 Randomized Controlled Trial

A. Blamire, D. Howel, J. Newton, 2018, Hepatology.

Symptoms of PBC - Pathophysiology and management.

A. Khanna, David E. J. Jones, J. Leighton, 2018, Best practice & research. Clinical gastroenterology.

Access to care in rare liver diseases: New challenges and new opportunities.

A. Lohse, David E. J. Jones, E. Sturm, 2017, Journal of hepatology.

TGF-β2 silencing to target biliary-derived liver diseases

M. Ebert, S. Dooley, D. Schuppan, 2020, Gut.

Microvascular optical assessment confirms the presence of peripheral autonomic dysfunction in primary biliary cirrhosis

A. Murray, John Allen, J. Newton, 2009, Liver international : official journal of the International Association for the Study of the Liver.

World enough and time

David E. J. Jones, David E. H. Jones, 1989, Nature.

Impact of primary biliary cirrhosis on perceived quality of life: The UK‐PBC national study

A. Burroughs, G. Alexander, J. Neuberger, 2013, Hepatology.

The academic sphere

David E. J. Jones, David E. H. Jones, 1996, Nature.

A key role for autoreactive B cells in the breakdown of T‐cell tolerance to pyruvate dehydrogenase complex in the mouse

David C. Jones, J. Kirby, David E. J. Jones, 2005, Hepatology.

Impaired cardiovascular function in primary biliary cirrhosis.

A. Blamire, G. MacGowan, Roy Taylor, 2010, American journal of physiology. Gastrointestinal and liver physiology.

Impaired cardiovascular response to standing in Chronic Fatigue Syndrome

A. Blamire, Roy Taylor, J. Newton, 2010, European journal of clinical investigation.

A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA.

D. Magrez, K. Kowdley, V. Luketic, 2021, Journal of hepatology.

Novel strategies and therapeutic options for the management of primary biliary cholangitis

A. Khanna, David E. J. Jones, 2017, Therapeutic advances in gastroenterology.

Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.

Robert L. Martin, B. Bacon, C. Mcwherter, 2017, The lancet. Gastroenterology & hepatology.

Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis

L. Peltonen, C. Anderson, H. Cordell, 2011, Nature Genetics.

Title: Reduced Heart Rate Variability and Baroreflex Sensitivity in Primary Biliary Cirrhosis

John Allen, J. Newton, David E. J. Jones, 2008 .

Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis

David C. Jones, John Allen, J. Newton, 2006, Liver international : official journal of the International Association for the Study of the Liver.

A predictive model for fatigue and its etiologic associations in primary biliary cirrhosis.

J. Newton, David E. J. Jones, J. Pairman, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis

David C. Jones, J. Newton, David E. J. Jones, 2007, Hepatology.

Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis.

David C. Jones, S. Pearce, A. Floreani, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease

J. Newton, David E. J. Jones, C. Day, 2009, Clinical Autonomic Research.

J. Newton, David E. J. Jones, M. Hudson, 2014, Journal of hepatology.

Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score

A. Khanna, David E. J. Jones, J. Dyson, 2016, Digestive Diseases and Sciences.

British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis

G. Alexander, S. Rushbrook, David E. J. Jones, 2019, Gut.

Amino acid residues in five separate HLA genes can explain most of the known associations between the MHC and primary biliary cholangitis

C. Anderson, H. Cordell, G. Alexander, 2018, PLoS genetics.

A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis

S. Medendorp, B. Bacon, V. Luketic, 2019, Hepatology communications.

Dyson JK, Elsharkawy AM, Lamb CA, Al-Rifai A, Newton JL, Jones DE, Hudson M. Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output. Liver International 2015, 35(5), 1633-1641

C. Lamb, J. Newton, David E. J. Jones, 2015 .

Fatigue in primary sclerosing cholangitis is associated with sympathetic over‐activity and increased cardiac output

C. Lamb, J. Newton, David E. J. Jones, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis

Daniel J. Gaffney, J. Barrett, C. Anderson, 2012, Nature Genetics.

A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis

David E. J. Jones, U. Beuers, R. O. Oude Elferink, 2015, Frontline Gastroenterology.

Abnormalities of AMPK Activation and Glucose Uptake in Cultured Skeletal Muscle Cells from Individuals with Chronic Fatigue Syndrome

M. Walker, J. Newton, David E. J. Jones, 2015, PloS one.

Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease

David E. J. Jones, M. Vidali, E. Albano, 2004, Hepatology.

Obeticholic acid for the treatment of primary biliary cirrhosis

David E. J. Jones, 2016, Expert review of gastroenterology & hepatology.

Bile Acid Transporters: Role in Health and Disease

David E. J. Jones, G. Hirschfield, V. Hegade, 2017 .

Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis

David E. J. Jones, G. Hirschfield, V. Hegade, 2017, Digestive Diseases.

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution

D. Absher, L. Peltonen, S. Mccarroll, 2011, Nature Genetics.

Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus

S. Taylor-Robinson, E. Holmes, J. Marchesi, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Pathological fatigue in chronic liver disease and tool for its assessment –experts’ decision

David E. J. Jones, A. Nersesov, P. Gabunia, 2019 .

Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case–control study

A. Blamire, M. Trenell, D. Jakovljevic, 2012, European journal of clinical investigation.

Editorial: rapid assessment of health‐related quality of life in primary biliary cholangitis—no excuse not to ask. Authors' reply

David E. J. Jones, G. Mells, Steven Flack, 2020, Alimentary pharmacology & therapeutics.

Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis

David E. J. Jones, Mona L. Martin, A. Joshi, 2019, Journal of Patient-Reported Outcomes.

Widespread gaps in the quality of care for primary biliary cholangitis in UK

A. Marshall, David E. J. Jones, A. Gandhi, 2021, Frontline Gastroenterology.

Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER

A. Lohse, J. Drenth, David E. J. Jones, 2019, Orphanet Journal of Rare Diseases.

NI‐0801, an anti‐chemokine (C‐X‐C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid

R. Chapman, S. Curbishley, A. Floreani, 2018, Hepatology communications.

What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis?

David E. J. Jones, V. Hegade, L. Wong, 2017, Digestive Diseases.

Diagnosis and management of patients with primary biliary cirrhosis

David E. J. Jones, J. Dyson, 2014, Clinical liver disease.

Rituximab for the treatment of fatigue in primary biliary cholangitis (formerly primary biliary cirrhosis): a randomised controlled trial

A. Blamire, D. Howel, D. Houghton, 2018 .

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.

Holly F. Ainsworth, V. Ronca, H. Cordell, 2018, The lancet. Gastroenterology & hepatology.

Clinical application of the GLOBE and United Kingdom‐primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis

David E. J. Jones, G. Mells, M. Carbone, 2018, Hepatology communications.

Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid.

G. Alexander, J. Neuberger, R. Sandford, 2013, Gastroenterology.

Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis

David E. J. Jones, J. Mann, C. Day, 2010, Hepatology.

Lower Ambulatory Blood Pressure in Chronic Fatigue Syndrome

J. Newton, David E. J. Jones, J. Pairman, 2009, Psychosomatic medicine.

Management of Fatigue in Primary Biliary Cholangitis

A. Khanna, David E. J. Jones, V. Hegade, 2019, Current Hepatology Reports.

The Canadian multi-center double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis: Heathcote EJ, Cauch-Duder K, Walker V, Bailey RJ, Blendis LM, Ghent CM, Michieletti P, et al. Hepatology 1994;19:1149–1156

David E. J. Jones, M. Bassendine, O. James, 1995 .

Ursodeoxycholic acid therapy in primary biliary cirrhosis

David E. J. Jones, M. Bassendine, O. James, 1995, Hepatology.

Oral Tolerisation to Pyruvate Dehydrogenase Complex as a Potential Therapy for Primary Biliary Cirrhosis

J. Kirby, David E. J. Jones, Amanda J. Robe, 2002, Autoimmunity.

Pathogenesis of primary biliary cirrhosis.

David E. J. Jones, 2008, Clinics in liver disease.

Pathogenesis of primary biliary cirrhosis.

David E. J. Jones, 2003, Journal of hepatology.

Emerging drugs for the treatment of primary biliary cholangitis

David E. J. Jones, J. Dyson, Naw April Phaw, 2020, Expert opinion on emerging drugs.

Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof‐of‐concept study

K. Lindor, David E. J. Jones, G. Hirschfield, 2016, Hepatology.

Unmet clinical need in autoimmune liver diseases.

A. Lohse, David E. J. Jones, G. Hirschfield, 2015, Journal of hepatology.

A potential retroviral aetiology for mouse PBC: more answers or more questions?

David E. J. Jones, 2011, Journal of hepatology.

Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis

C. Mcwherter, David E. J. Jones, G. Hirschfield, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Itch and liver: management in primary care.

David E. J. Jones, Stuart Kendrick, V. Hegade, 2015, The British journal of general practice : the journal of the Royal College of General Practitioners.

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

I. Mackay, R. Gish, David E. J. Jones, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Pathogenesis of Primary Biliary Cirrhosis

David E. J. Jones, 2007, Gut.

Primary Biliary Cirrhosis

David C. Jones, David E. J. Jones, 2004, Autoimmunity.

Drug treatment of pruritus in liver diseases.

David E. J. Jones, Stuart Kendrick, V. Hegade, 2015, Clinical medicine.

Technical boundless optimism

David E. J. Jones, 1995, Nature.

AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Xenobiotic Incorporation into Pyruvate Dehydrogenase Complex Can Occur Via the Exogenous Lipoylation Pathway

David C. Jones, J. Kirby, David E. J. Jones, 2008 .

Fatal gastrointestinal histoplasmosis 15 years after orthotopic liver transplantation

S. Needham, David E. J. Jones, N. Thompson, 2017, World journal of gastroenterology.

Fatigue in chronic liver disease: New insights and therapeutic approaches

M. Swain, David E. J. Jones, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Chronic liver disease in an ageing population.

J. Newton, David E. J. Jones, J. Frith, 2008, Age and ageing.

Reduced thoracic fluid content in early-stage primary biliary cirrhosis that associates with impaired cardiac inotropy.

J. Newton, David E. J. Jones, P. Zalewski, 2013, American journal of physiology. Gastrointestinal and liver physiology.

The New Epidemiology of Primary Biliary Cirrhosis

David E. J. Jones, L. Griffiths, J. Dyson, 2014, Seminars in Liver Disease.

The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines

G. Alexander, S. Hübscher, David E. J. Jones, 2018, Gut.

Genetic factors in the pathogenesis of primary biliary cirrhosis.

P. Donaldson, David E. J. Jones, 2003, Clinics in liver disease.

The challenges of primary biliary cholangitis: What is new and what needs to be done.

M. Manns, K. Tsuneyama, D. Vergani, 2019, Journal of autoimmunity.

A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome

Anil Wipat, Ian Giles, Jennifer Hallinan, 2015, PloS one.

Obeticholic Acid in Primary Biliary Cholangitis.

F. Nevens, K. Lindor, David E. J. Jones, 2016, The New England journal of medicine.

Primary biliary cirrhosis: new perspectives in diagnosis and treatment

David E. J. Jones, M. Prince, Martin I Prince, 2000, Postgraduate medical journal.

Fatigue in Primary Biliary Cirrhosis: Prevalence, Pathogenesis and Management

L. Jopson, David E. J. Jones, 2015, Digestive Diseases.

Pathogenesis of Primary Biliary Cirrhosis and Its Fatigue

David E. J. Jones, L. Griffiths, Laura Griffiths, 2014, Digestive Diseases.

The role of psychological factors in the fatigue of primary biliary cirrhosis

M. Freeston, J. Newton, David E. J. Jones, 2007, Liver international : official journal of the International Association for the Study of the Liver.

The true impact of fatigue in primary biliary cirrhosis: a population study.

David E. J. Jones, M. Bassendine, O. James, 2002, Gastroenterology.

Primary Biliary Cholangitis

David E. J. Jones, 2018, Sherlock's Diseases of the Liver and Biliary System.

Early Molecular Stratification of High-risk Primary Biliary Cholangitis

M. Haniffa, L. Jopson, David E. J. Jones, 2016, EBioMedicine.

Novel therapeutic targets in primary biliary cirrhosis

D. Adams, K. Lindor, David E. J. Jones, 2015, Nature Reviews Gastroenterology &Hepatology.

The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort.

A. Burroughs, G. Alexander, J. Neuberger, 2013, Journal of hepatology.

Primary sclerosing cholangitis

A. Lohse, David E. J. Jones, M. Hudson, 2018, The Lancet.

Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease

M. Pekalski, J. Kirby, David E. J. Jones, 2008, Laboratory Investigation.

Tumour necrosis factor-a promoter polymorphisms in primary biliary cirrhosis

J. Newton, David E. J. Jones, J. Grove, 1999 .

What impact has the NIHR Academic Clinical Fellowship (ACF) scheme had on clinical academic careers in England over the last 10 years? A retrospective study

David E. J. Jones, Caroline Magee, J. Neilson, 2017, BMJ Open.

Functional capacity is significantly impaired in primary biliary cirrhosis and is related to orthostatic symptoms

J. Newton, David E. J. Jones, J. Pairman, 2011, European journal of gastroenterology & hepatology.

BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial

G. Alexander, David E. J. Jones, G. Hirschfield, 2016, BMC Gastroenterology.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

I. Mackay, R. Gish, David E. J. Jones, 2015, Journal of hepatology.

The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study.

J. Neuberger, David E. J. Jones, M. Carbone, 2013, Journal of hepatology.

Reduction in functional ability is significant postliver transplantation compared with matched liver disease and community dwelling controls

J. Newton, David E. J. Jones, J. Pairman, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’

David C. Jones, I. Mackay, R. Gish, 2015, Gut.

Arsenic in Napoleon's wallpaper

K. Ledingham, David E. J. Jones, 1982, Nature.

Assessing quality of life in primary biliary cirrhosis.

A. Jacoby, D. Buck, David E. J. Jones, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The genetics of primary biliary cirrhosis: The revolution moves on

David E. J. Jones, G. Mells, 2011, Hepatology.

Development of an Evidence-Based Patient Information Medium: Empowering Newly Diagnosed Patients With Primary Biliary Cirrhosis

J. Newton, Ruth Pearce, David E. J. Jones, 2011, Journal of visual communication in medicine.

Comment on biochemical response to ursodeoxycholic acid and long‐term prognosis in primary biliary cirrhosis

J. Newton, David E. J. Jones, M. Bassendine, 2009, Hepatology.

Addison's other disease: primary biliary cirrhosis as a model autoimmune disease.

David E. J. Jones, 2003, Clinical medicine.

Natural history of early primary biliary cirrhosis

David E. J. Jones, M. Bassendine, O. James, 1996, The Lancet.

Tumour necrosis factor-α promoter polymorphisms in primary biliary cirrhosis

J. Newton, David E. J. Jones, J. Grove, 1999 .

PBC‐10: a short quality of life measure for clinical screening in primary biliary cholangitis

David E. J. Jones, G. Mells, Steven Flack, 2019, Alimentary pharmacology & therapeutics.

Cardiac torsion-strain relationships in fatigued primary biliary cirrhosis patients show accelerated aging: a pilot cross-sectional study

A. Blamire, G. MacGowan, Roy Taylor, 2012, Journal of applied physiology.

Fatigue in cholestatic liver disease: is it all in the mind?

David E. J. Jones, 2007, Journal of hepatology.

Managing systemic symptoms in chronic liver disease.

J. Newton, David E. J. Jones, 2012, Journal of hepatology.

Central nervous system dysfunction in primary biliary cirrhosis and its relationship to symptoms.

S. Baker, J. Newton, David E. J. Jones, 2010, Journal of hepatology.

Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity

J. Newton, David E. J. Jones, J. Pairman, 2007, European journal of gastroenterology & hepatology.

Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence

J. Newton, David E. J. Jones, M. Tomlinson, 2006, Hepatology.

Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure.

J. Newton, David E. J. Jones, Julia L Newton, 2006, Journal of hepatology.

Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom.

G. Alexander, R. Sandford, David E. J. Jones, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Fatigue in primary biliary cirrhosis

J. Newton, David E. J. Jones, M. Hale, 2012, BMJ : British Medical Journal.

Loss of capacity to recover from acidosis in repeat exercise is strongly associated with fatigue in primary biliary cirrhosis.

A. Blamire, Roy Taylor, J. Newton, 2010, Journal of hepatology.

Pilot study of peripheral muscle function in primary biliary cirrhosis: potential implications for fatigue pathogenesis.

A. Blamire, Roy Taylor, J. Newton, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study

David E. J. Jones, G. Hirschfield, U. Beuers, 2017, The Lancet.

Understanding and Treating Fatigue in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis.

L. Jopson, David E. J. Jones, J. Dyson, 2016, Clinics in liver disease.

Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom.

S. Taylor-Robinson, R. Sandford, L. Vale, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Complications of cholestasis

David E. J. Jones, V. Hegade, 2002, Medicine.

Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness

A. Khanna, L. Jopson, David E. J. Jones, 2018, Digestive Diseases and Sciences.

Managing cognitive symptoms and fatigue in cholestatic liver disease

David E. J. Jones, J. Leighton, J. Dyson, 2020, Expert review of gastroenterology & hepatology.

PBC: Better Solutions to Beat Feeling Beat

David E. J. Jones, Naw April Phaw, 2019, Digestive Diseases and Sciences.

Falls and Fall-Related Injury Are Common in Older People with Chronic Liver Disease

J. Newton, David E. J. Jones, C. Day, 2012, Digestive Diseases and Sciences.

Making sense of fatigue.

J. Newton, David E. J. Jones, 2010, Occupational medicine.

An integrated care pathway improves quality of life in Primary Biliary Cirrhosis.

Katy Sutcliffe, J. Newton, David E. J. Jones, 2008, QJM : monthly journal of the Association of Physicians.

Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease.

J. Newton, David E. J. Jones, C. Day, 2010, Journal of hepatology.

Restless leg syndrome is a treatable cause of sleep disturbance and fatigue in primary biliary cirrhosis

J. Newton, K. Anderson, David E. J. Jones, 2013, Liver international : official journal of the International Association for the Study of the Liver.

A follow‐up study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis

J. Newton, David E. J. Jones, T. Hardy, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Novel bile acid therapeutics for the treatment of chronic liver diseases

David E. J. Jones, R. A. Speight, V. Hegade, 2016, Therapeutic advances in gastroenterology.

The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility

D. Stocken, Y. Oo, A. Khanna, 2018, Hepatology.

The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: results of a 9 year follow-up.

J. Newton, David E. J. Jones, J. Frith, 2010, Journal of hepatology.

Reduced pallidal magnetisation transfer ratios are associated with fatigue in pre-cirrhotic patients with primary biliary cirrhosis (PBC)

J. Allsop, H. Thomas, S. Taylor-Robinson, 2002 .

ORIGINAL ARTICLES—LIVER, PANCREAS, AND BILIARY TRACT A Predictive Model for Fatigue and Its Etiologic Associations in Primary Biliary Cirrhosis

J. Newton, David E. J. Jones, J. Pairman, 2008 .

Globus pallidus magnetization transfer ratio, T1 and T2 in primary biliary cirrhosis: Relationship with disease stage and age

Benjamin S. Aribisala, A. Blamire, Roy Taylor, 2009, Journal of magnetic resonance imaging : JMRI.

Autonomic dysfunction in primary biliary cirrhosis is associated with structural brain abnormalities, particularly in the globus pallidus

A. Blamire, Roy Taylor, J. Newton, 2007 .

Functional Impairment in Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease Is Significant and Persists over 3 Years of Follow-Up

J. Newton, David E. J. Jones, C. Day, 2013, Digestive Diseases and Sciences.

BAT 117213 : Ileal bile acid transporter ( IBAT ) inhibition as a treatment for pruritus in primary biliary cirrhosis : study protocol for a randomised controlled trial

G. Alexander, David E. J. Jones, G. Hirschfield, 2016 .

Theophylline improves steroid sensitivity in acute alcoholic hepatitis

David E. J. Jones, C. Day, E. Henderson, 2010, Hepatology.

A Novel Method for Continuous, Noninvasive, Cuff-Less Measurement of Blood Pressure: Evaluation in Patients With Nonalcoholic Fatty Liver Disease

Trine M. Seeberg, Frode Strisland, David E. J. Jones, 2017, IEEE Transactions on Biomedical Engineering.

Unmet needs and new models for future trials in autoimmune hepatitis.

M. Manns, M. Torbenson, L. Terracciano, 2018, The lancet. Gastroenterology & hepatology.

Bile acid receptor agonists in primary biliary cholangitis: Regulation of the cholangiocyte secretome and downstream T cell differentiation

J. Kirby, David E. J. Jones, Ben Millar, 2019, FASEB bioAdvances.

Measuring fatigue in medically unwell and distressed patients

David E. J. Jones, M. Prince, 2001 .

Cognitive impairment in non-cirrhotic chronic liver disease is unrelated to liver disease severity but associated with ineffective baroreflex function

J. Newton, David E. J. Jones, G. Fattakhova, 2011, Gut.

Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’

I. Mackay, R. Gish, David E. J. Jones, 2015, Gut.

Investigation of a Mechanism for Accelerated Breakdown of Immune Tolerance to the Primary Biliary Cirrhosis–Associated Autoantigen, Pyruvate Dehydrogenase Complex

J. Kirby, David E. J. Jones, A. Burt, 2002, Laboratory Investigation.

Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging Stigma

David E. J. Jones, J. Leighton, D. Thorburn, 2021, Digestive Diseases and Sciences.